Skip to main content

US ClosedU.S. Closed

DMRA: Damora Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Damora Therapeutics, Inc. , a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America.

52W Range

74thpctl

Volume

0.75×avg

Market Cap

1.79BUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Damora Therapeutics, Inc.

DMRANASDAQ Capital Market·USD·Closed

Damora Therapeutics, Inc.

DMRANASDAQ·USD·Closed

$29.00

−5.23%

$29.00

−$1.60 (5.23%)

52W Range

74thpctl

Volume

0.75×avg

Mkt Cap

1.79BUSD

P/E

-0.2TTM

Div Yield

–ann